Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dingell food safety bill

This article was originally published in The Tan Sheet

Executive Summary

House Energy and Commerce Chairman John Dingell's, D-Mich., draft legislation on food safety would require FDA to collect user fees on food imported into the U.S., with the revenue used to support import inspections, lab testing on import samples and research on testing techniques for intentionally adulterated food imports. The bill, which had not been filed or assigned a number as of Aug. 10, would also prevent FDA from closing or consolidating its 13 FDA field laboratories, Dingell says in an Aug. 3 release. "Without regular inspections and analysis there is little incentive for food producers and importers to ensure that our food supply is free from harmful and sometimes fatal contaminants," he says. The bill would grant FDA authority to issue mandatory recalls; require country of origin labeling; limit the number of ports of entry for food items; halt imports of certain products until a foreign facility can demonstrate that significant steps have been taken to rectify an identified problem; and increase civil monetary penalties for manufacturers or importers that violate the Food, Drug and Cosmetic Act. Dingell has been a frequent critic of FDA's food safety oversight and has said he would introduce legislation to bring about sweeping changes (1"The Tan Sheet" July 9, 2007, p. 9)...

You may also be interested in...



Counterfeit Drugs, Food Safety Are Expected Focus Of New FDA Bill In House

Tightened security for counterfeit drugs and food imports are slated to be addressed in another bill aimed at boosting FDA's oversight powers, Energy and Commerce Committee Chairman John Dingell, D-Mich., said during markup of drug safety legislation

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.

Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval

The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100794

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel